| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 135, 815-825, Copyright © 1989 by American Society for Investigative Pathology
REGULAR ARTICLES |
HC Boyd, AM Gown, G Wolfbauer and A Chait
Department of Pathology, University of Washington, Seattle 98195.
Low density lipoproteins (LDL) that have been oxidatively modified have been implicated in the pathogenesis of atherosclerosis. Monoclonal antibodies were generated against oxidatively modified human low density lipoproteins (OxLDL); these antibodies reacted with OxLDL, but did not react with native LDL, either in an enzyme-linked immunosorbent assay (ELISA) or a Western blot analysis. The anti-OxLDL antibodies did react with other modified forms of LDL (eg, acetylated LDL, malondialdehyde-modified LDL, and cell-modified LDL) that were recognized by the scavenger receptor on macrophages. Single- and double- label immunofluorescence of atheromatous lesions from a Watanabe heritable hyperlipidemic (WHHL) rabbit demonstrated some colocalization of proteins detected by anti-LDL and anti-OxLDL antibodies. However, clearly there were also areas stained by the anti-OxLDL antibodies that did not stain with anti-LDL. Staining of the lesion by the anti-OxLDL antibody was abolished by adsorption of the antibody with OxLDL, but not by adsorption with LDL or bovine serum albumin. Arterial tissue from a control New Zealand White rabbit did not show staining with anti- LDL or anti-OxLDL antibodies. These observations suggest that OxLDL (or possibly other proteins recognized by the anti-OxLDL antibody) is present in atheromatous lesions of WHHL rabbits, and are consistent with oxidatively modified lipoproteins having a role in atherogenesis.
This article has been cited by other articles:
 |
|
 |
|
  X. Zhou, A.-K. L. Robertson, C. Hjerpe, and G. K. Hansson Adoptive Transfer of CD4+ T Cells Reactive to Modified Low-Density Lipoprotein Aggravates Atherosclerosis Arterioscler. Thromb. Vasc. Biol., April 1, 2006; 26(4): 864 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Shoenfeld, R. Wu, L. D. Dearing, and E. Matsuura Are Anti-Oxidized Low-Density Lipoprotein Antibodies Pathogenic or Protective? Circulation, October 26, 2004; 110(17): 2552 - 2558. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Stocker and J. F. Keaney Jr. Role of Oxidative Modifications in Atherosclerosis Physiol Rev, October 1, 2004; 84(4): 1381 - 1478. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-P. Wang, X.-J. Feng, B.-D. Gou, T.-L. Zhang, S.-J. Xu, and K. Wang Effects of LDL, Cholesterol, and Their Oxidized Forms on the Precipitation Kinetics of Calcium Phosphates Clin. Chem., December 1, 2003; 49(12): 2027 - 2036. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. PALINSKI and C. NAPOLI The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis FASEB J, September 1, 2002; 16(11): 1348 - 1360. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Monaco, F. Crea, G. Niccoli, F. Summaria, D. Cianflone, R. Bordone, G. Bellomo, and A. Maseri Autoantibodies against oxidized low density lipoproteins in patients with stable angina, unstable angina or peripheral vascular disease; pathophysiological implications Eur. Heart J., September 1, 2001; 22(17): 1572 - 1577. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Y. Chang, S. Potter-Perigo, T. N. Wight, and A. Chait Oxidized LDL bind to nonproteoglycan components of smooth muscle extracellular matrices J. Lipid Res., May 1, 2001; 42(5): 824 - 833. [Abstract] [Full Text]
|
|
|
|
|
|
S. Tsimikas, W. Palinski, and J. L. Witztum Circulating Autoantibodies to Oxidized LDL Correlate With Arterial Accumulation and Depletion of Oxidized LDL in LDL Receptor-Deficient Mice Arterioscler. Thromb. Vasc. Biol., January 1, 2001; 21(1): 95 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zhou, G. Caligiuri, A. Hamsten, A. K. Lefvert, and G. K. Hansson LDL Immunization Induces T-Cell-Dependent Antibody Formation and Protection Against Atherosclerosis Arterioscler. Thromb. Vasc. Biol., January 1, 2001; 21(1): 108 - 114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. G. de Oliveira, C. L. Rossi, M. G. de Oliveira, M. J.A. Saad, and L. A. Velloso Effect of vitamin E supplementation on antibody levels against malondialdehyde modified LDL in hyperlipidemic hamsters Cardiovasc Res, August 18, 2000; 47(3): 567 - 573. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Cominacini, A. F. Pasini, U. Garbin, A. Davoli, M. L. Tosetti, M. Campagnola, A. Rigoni, A. M. Pastorino, V. Lo Cascio, and T. Sawamura Oxidized Low Density Lipoprotein (ox-LDL) Binding to ox-LDL Receptor-1 in Endothelial Cells Induces the Activation of NF-kappa B through an Increased Production of Intracellular Reactive Oxygen Species J. Biol. Chem., April 21, 2000; 275(17): 12633 - 12638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Tsimikas, B. P. Shortal, J. L. Witztum, and W. Palinski In Vivo Uptake of Radiolabeled MDA2, an Oxidation-Specific Monoclonal Antibody, Provides an Accurate Measure of Atherosclerotic Lesions Rich in Oxidized LDL and Is Highly Sensitive to Their Regression Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 689 - 697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Nakata, Y. Nakagawa, M. Nishida, S. Nozaki, J.-i. Miyagawa, T. Nakagawa, R. Tamura, K. Matsumoto, K. Kameda-Takemura, S. Yamashita, et al. CD36, a Novel Receptor for Oxidized Low-Density Lipoproteins, Is Highly Expressed on Lipid-Laden Macrophages in Human Atherosclerotic Aorta Arterioscler. Thromb. Vasc. Biol., May 1, 1999; 19(5): 1333 - 1339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Freigang, S. Horkko, E. Miller, J. L. Witztum, and W. Palinski Immunization of LDL Receptor–Deficient Mice With Homologous Malondialdehyde-Modified and Native LDL Reduces Progression of Atherosclerosis by Mechanisms Other Than Induction of High Titers of Antibodies to Oxidative Neoepitopes Arterioscler. Thromb. Vasc. Biol., December 1, 1998; 18(12): 1972 - 1982. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Koskinen, C. Enockson, M. F. Lopes-Virella, and G. Virella Preparation of a Human Standard for Determination of the Levels of Antibodies to Oxidatively Modified Low-Density Lipoproteins Clin. Vaccine Immunol., November 1, 1998; 5(6): 817 - 822. [Abstract] [Full Text]
|
|
|
|
|
|
T. Nakagawa, S. Nozaki, M. Nishida, J. M. Yakub, Y. Tomiyama, A. Nakata, K. Matsumoto, T. Funahashi, K. Kameda-Takemura, Y. Kurata, et al. Oxidized LDL Increases and Interferon-{gamma} Decreases Expression of CD36 in Human Monocyte–Derived Macrophages Arterioscler. Thromb. Vasc. Biol., August 1, 1998; 18(8): 1350 - 1357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Bird, R. K. Tangirala, J. Fruebis, D. Steinberg, J. L. Witztum, and W. Palinski Effect of probucol on LDL oxidation and atherosclerosis in LDL receptor-deficient mice J. Lipid Res., May 1, 1998; 39(5): 1079 - 1090. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Torzewski, M. Klouche, J. Hock, M. Meßner, B. Dorweiler, J. Torzewski, H. E. Gabbert, and S. Bhakdi Immunohistochemical Demonstration of Enzymatically Modified Human LDL and Its Colocalization With the Terminal Complement Complex in the Early Atherosclerotic Lesion Arterioscler. Thromb. Vasc. Biol., March 1, 1998; 18(3): 369 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Takagi, M. Ueda, A. E. Becker, K. Takeuchi, and T. Takeda The Watanabe Heritable Hyperlipidemic Rabbit Is a Suitable Experimental Model to Study Differences in Tissue Response Between Intimal and Medial Injury After Balloon Angioplasty Arterioscler. Thromb. Vasc. Biol., December 1, 1997; 17(12): 3611 - 3619. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Horkko, E. Miller, D. W. Branch, W. Palinski, and J. L. Witztum The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta 2 glycoprotein 1 (and other proteins) PNAS, September 16, 1997; 94(19): 10356 - 10361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Mabile, O. Meilhac, I. Escargueil-Blanc, M. Troly, M.-T. Pieraggi, R. Salvayre, and A. Negre-Salvayre Mitochondrial Function Is Involved in LDL Oxidation Mediated by Human Cultured Endothelial Cells Arterioscler. Thromb. Vasc. Biol., August 1, 1997; 17(8): 1575 - 1582. [Abstract] [Full Text]
|
|
|
|
|
|
K. D. O'Brien, C. E. Alpers, J. E. Hokanson, S. Wang, and A. Chait Oxidation-Specific Epitopes in Human Coronary Atherosclerosis Are Not Limited to Oxidized Low-Density Lipoprotein Circulation, September 15, 1996; 94(6): 1216 - 1225. [Abstract] [Full Text]
|
|
|
|
|
|
I. Staprans, J. H. Rapp, X.-M. Pan, D. A. Hardman, and K. R. Feingold Oxidized Lipids in the Diet Accelerate the Development of Fatty Streaks in Cholesterol-Fed Rabbits Arterioscler. Thromb. Vasc. Biol., April 1, 1996; 16(4): 533 - 538. [Abstract] [Full Text]
|
|
|
|
|
|
K. D. O'Brien, T. O. McDonald, A. Chait, M. D. Allen, and C. E. Alpers Neovascular Expression of E-Selectin, Intercellular Adhesion Molecule-1, and Vascular Cell Adhesion Molecule-1 in Human Atherosclerosis and Their Relation to Intimal Leukocyte Content Circulation, February 15, 1996; 93(4): 672 - 682. [Abstract] [Full Text]
|
|
|
|
|
|
W. Palinski, R. K. Tangirala, E. Miller, S. G. Young, and J. L. Witztum Increased Autoantibody Titers Against Epitopes of Oxidized LDL in LDL Receptor–Deficient Mice With Increased Atherosclerosis Arterioscler. Thromb. Vasc. Biol., October 1, 1995; 15(10): 1569 - 1576. [Abstract] [Full Text]
|
|
|
|
|
|
R. K. Tangirala, F. Casanada, E. Miller, J. L. Witztum, D. Steinberg, and W. Palinski Effect of the Antioxidant N,N'-Diphenyl 1,4-Phenylenediamine (DPPD) on Atherosclerosis in ApoE-Deficient Mice Arterioscler. Thromb. Vasc. Biol., October 1, 1995; 15(10): 1625 - 1630. [Abstract] [Full Text]
|
|
|
|
|
|
M. Y. Chang, M. Sasahara, A. Chait, E. W. Raines, and R. Ross Inhibition of Hypercholesterolemia-Induced Atherosclerosis in the Nonhuman Primate by Probucol : II. Cellular Composition and Proliferation Arterioscler. Thromb. Vasc. Biol., October 1, 1995; 15(10): 1631 - 1640. [Abstract] [Full Text]
|
|
|
|
|
|
E. Malle, L. Hazell, R. Stocker, W. Sattler, H. Esterbauer, and G. Waeg Immunologic Detection and Measurement of Hypochlorite-Modified LDL With Specific Monoclonal Antibodies Arterioscler. Thromb. Vasc. Biol., July 1, 1995; 15(7): 982 - 989. [Abstract] [Full Text]
|
|
|
|
|
|
M. O. Pentikainen, K. A. Lindstedt, and P. T. Kovanen Inhibition of the Oxidative Modification of LDL by Nitecapone Arterioscler. Thromb. Vasc. Biol., June 1, 1995; 15(6): 740 - 747. [Abstract] [Full Text]
|
|
|
|
|
|
W. Palinski, T. Koschinsky, S. W. Butler, E. Miller, H. Vlassara, A. Cerami, and J. L. Witztum Immunological Evidence for the Presence of Advanced Glycosylation End Products in Atherosclerotic Lesions of Euglycemic Rabbits Arterioscler. Thromb. Vasc. Biol., May 1, 1995; 15(5): 571 - 582. [Abstract] [Full Text]
|
|
|
|
|
|
A. Hammer, G. Kager, G. Dohr, H. Rabl, I. Ghassempur, and G. Jurgens Generation, Characterization, and Histochemical Application of Monoclonal Antibodies Selectively Recognizing Oxidatively Modified ApoB-Containing Serum Lipoproteins Arterioscler. Thromb. Vasc. Biol., May 1, 1995; 15(5): 704 - 713. [Abstract] [Full Text]
|
|
|
|
|
|
C. Bergmark, R. Wu, U. d. Faire, A. K. Lefvert, and J. Swedenborg Patients With Early-Onset Peripheral Vascular Disease Have Increased Levels of Autoantibodies Against Oxidized LDL Arterioscler. Thromb. Vasc. Biol., April 1, 1995; 15(4): 441 - 445. [Abstract] [Full Text]
|
|
|
|
|
|
I. Jialal, C. J. Fuller, and B. A. Huet The Effect of {alpha}-Tocopherol Supplementation on LDL Oxidation : A Dose-Response Study Arterioscler. Thromb. Vasc. Biol., February 1, 1995; 15(2): 190 - 198. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
